A study published in Science Advances found that vesper bats, the world’s largest bat family, carry two distinct copies of ...
Why does the same infection cause only mild symptoms in one person but more serious disease in another? A new study led by ...
Radiotherapy augments immunotherapy, yet conventional 2 Gy x-ray fractions largely induce apoptosis, whereas robust ...
Enrollment and dosing completed in Phase 1 randomized controlled trial (n=144) evaluating the safety, tolerability, immunogenicity and ...
Antigen-specific humoral responses are critical for long-term protection against infectious diseases, yet the mechanisms that ...
A compound targeting serotonin receptor 5-HT2A (5-HT2AR) signaling in the gut could activate antitumor immunity in colorectal cancer (CRC) and improve responses to immunotherapy without causing ...
ImmunityBio offers a best-in-class, approved immunotherapy, ANKTIVA, driving rapid revenue growth and significant market share in NMIBC. IBRX’s pipeline is robust, with multiple Phase 1-3 trials ...
Add Yahoo as a preferred source to see more of our stories on Google. A cross-section of a bristle worm jaw sample with the indentation testing sites labeled 1 to 11. (CREDIT: Zelaya-Lainez et al.) ...
New research led by Mass General Brigham investigators suggests that the Bacillus Calmette-Guérin (BCG) vaccine—which is delivered through the skin to prevent tuberculosis—may remodel the human ...
In a silent war that has raged for millions of years, plants have evolved a sophisticated chemical arsenal to fight back against invading pathogens. Now, a team of researchers from Peking University ...
Shares of immunotherapy biotech ImmunityBio (NASDAQ: IBRX) initially popped today, and are up 9% as of 10:45 a.m. ET on Wednesday. After market close yesterday, ImmunityBio announced that the Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results